Log in with your email address username.


[Correspondence] Reporting of immune checkpoint inhibitor-associated myocarditis

We read with interest the Correspondence by Javid J Moslehi and colleagues (March 10, p 933),1 in which they reported an increase in reporting incidence of myocarditis associated with immune checkpoint inhibitors in WHO’s VigiBase database and shed insight on patient outcomes.